Patents by Inventor Esperanza Feijoo Blanco

Esperanza Feijoo Blanco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides with the capacity to bind to transforming growth factor ?1 (TGF-?1)
    Patent number: 8158589
    Abstract: The described peptides possess the capacity to bind to Transforming Growth Factor TGF-?1 (TGF-?1), and are potential inhibitors of the biological activity of TGF-?1 through direct binding to this cytokine. These peptides can be used in the treatment of diseases or pathological alterations based on excessive or deregulated TGF-?1 expression, e.g., liver fibrosis, pulmonary fibrosis, corneal fibrosis and haze.
    Type: Grant
    Filed: February 22, 2010
    Date of Patent: April 17, 2012
    Assignees: Proyecto Biomedicine Cima, S.L., Digna Biotech, S.L.
    Inventors: Javier Dotor Herrerías, Francisco Borrás Cuesta, Esperanza Feijoo Blanco
  • PEPTIDES WITH THE CAPACITY TO BIND TO TRANSFORMING GROWTH FACTOR beta 1 (TGF-beta 1)
    Publication number: 20100222280
    Abstract: The described peptides possess the capacity to bind to Transforming Growth Factor TGF-?1 (TGF-?1), and are potential inhibitors of the biological activity of TGF-?1 through direct binding to this cytokine. These peptides can be used in the treatment of diseases or pathological alterations based on excessive or deregulated TGF-?1 expression, e.g., liver fibrosis, pulmonary fibrosis, corneal fibrosis and haze.
    Type: Application
    Filed: February 22, 2010
    Publication date: September 2, 2010
    Inventors: JAVIER DOTOR HERRERÍAS, ANA BELÉN LÓPEZ VÁZQUEZ, JUAN JOSÉ LASARTE SAGASTIBELZA, JESÚS PRIETO VALTUEÑA, FRANCISCO BORRÁS CUESTA, ESPERANZA FEIJOO BLANCO